OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of various payloads from small molecules to large biologics through encapsulation and localized tumor targeting. OncoNano is passionate about generating a robust oncology pipeline to advance more precise therapies and better patient outcomes. Learn more about our platform and pipeline at www.OncoNano.com.